SEC Form D · filed October 29, 2019
Protagenic Therapeutics, Inc.\new
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Robert B. Stein · New York, NYDirectorKhalil B. Barrage · New York, NYDirectorGaro H. Armen · New York, NYExec · DirectorJoshua B. Silverman · New York, NYDirectorAlexander K. Arrow · New York, NYExecBrian J. Corvese · New York, NYDirectorChristopher T. Lacovara · New York, NYDirectorMarcelo Camberos · San Mateo, CADirectorJennifer Goldfarb · San Mateo, CAExec · DirectorJeffery C. Conn · The Woodlands, TXExecVirginia E. Riesing · MILWAUKEE, WIDirectorDean T. Kehler · New York, NYDirectorAlan Thielemann · Dunwoody, GAExec · DirectorAdam L. Alpert · Providence, RIDirectorNoah Rosenfarb · Parkland, FLExecRodney Wolterman · Vancouver, British Columbia, CanadaDirectorMichael Townsend · Vancouver, British Columbia, CanadaDirectorSean Cross · Frisco, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗